Infectious Disease Special Edition

Infectious Disease Special Edition Infectious Disease Special Edition (IDSE), is a comprehensive resource on treatments, procedures and infection prevention for healthcare providers.

Infectious Disease Special Edition (IDSE), is a bi-annual magazine that features features about infectious diseases and reviews written by ID experts. The magazine is read by infectious disease specialists, primary care physicians, epidemiologists, pharmacists, nurses and others involved in the treatment of infectious diseases. Each issue offers a collection of review articles written by leading clinicians and scientists. These reviews present topical, accurate, and comprehensive information on topics covering a wide range of patient populations and therapeutic areas. They are designed to serve as a “one-stop” resource for clinicians and researchers. IDSE takes into account the time constraints of its readers, and offers a compendium of clinical reference tools that are easy to read, with useful and clinical relevant drug tables and treatment algorithms designed to assist readers in their clinical practice.

World AIDS Day
12/01/2017
World AIDS Day

World AIDS Day

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Repro...

Today is World AIDS Day. The theme is "Everybody counts"  where everyone has access to safe, effective, quality and affo...
12/01/2017

Today is World AIDS Day. The theme is "Everybody counts" where everyone has access to safe, effective, quality and affordable HIV services, medicines, diagnostics other health commodities for all people who need them. Universal health coverage means that all people receive the health services they need without experiencing financial hardship, including access to the full range of HIV services.

HIV-Positive Patients Not Getting Cardiovascular Care
11/29/2017
Testing for HIV

HIV-Positive Patients Not Getting Cardiovascular Care

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Repro...

FDA Approves Prevymis CMV Prophylaxis
11/09/2017
FDA Approves Prevymis CMV Prophylaxis

FDA Approves Prevymis CMV Prophylaxis

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

GBS Major Cause of Infant Death and Stillbirths
11/08/2017
GBS Major Cause of Infant Death and Stillbirths

GBS Major Cause of Infant Death and Stillbirths

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

Top 5 Stories on the Web
11/01/2017
Top 5 Stories on the Web

Top 5 Stories on the Web

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

ACIP Recommends Shingrix for Adults 50 and Older
10/26/2017
ACIP Recommends Shingrix for Adults 50 and Older

ACIP Recommends Shingrix for Adults 50 and Older

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

9 Tools for a Better Antibiogram
10/25/2017
9 Tools for a Better Antibiogram

9 Tools for a Better Antibiogram

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

C. difficile Infection Management
10/18/2017
C. difficile Infection Management

C. difficile Infection Management

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

Infectious Diseases Society of America
10/13/2017

Infectious Diseases Society of America

IDSA and HIVMA strongly urge the Trump administration to send emergency funding to avert public health crises in Puerto Rico and the U.S. Virgin Islands. We need to act quickly to fight infectious diseases in these areas. Full statement: http://bit.ly/2wO5UcI

Winning the ‘Antibiotic Game’ With Pneumonia
10/13/2017
Antimicrobial Efficacy Ap

Winning the ‘Antibiotic Game’ With Pneumonia

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

Experimental HIV Drugs Look Positive
10/11/2017
Experimental HIV Drugs Look Positive

Experimental HIV Drugs Look Positive

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Reprod...

IDWeek: Preventing Pandemic Flu
10/06/2017
IDWeek: Preventing Pandemic Flu

IDWeek: Preventing Pandemic Flu

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net/ are part of McMahon Publishing. All rights reserved. Repro...

09/29/2017
Improving Antimicrobial Stewardship with Faster Susceptibility Results: Use of the Accelerate™ PhenoTest BC Kit

Read our new monograph on rapid testing and stewardship. http://www.idse.net/Monographs-and-Whitepapers/Article/09-17/Improving-Antimicrobial-Stewardship-with-Faster-Susceptibility-Results-em-Use-of-the-Accelerate-PhenoTest-BC-Kit-em-/44717

This monograph describes clinical experience using the Accelerate Pheno™ system in shortening time to optimal antibiotic therapy with standardized antimicrobial stewardship intervention practices.

Infectious Disease Special Edition's cover photo
09/27/2017

Infectious Disease Special Edition's cover photo

Infectious Disease Special Edition
09/27/2017

Infectious Disease Special Edition

From a Phase II EMERGE trial, a new interferon, peginterferon lambda-1a, may help improve treatment for patients with he...
03/06/2013
Souped-Up IFN Could Improve HCV Treatment

From a Phase II EMERGE trial, a new interferon, peginterferon lambda-1a, may help improve treatment for patients with hepatitis C (HCV). IDSE spoke with Andrew J. Muir, MD, MHS, the clinical director of hepatology at Duke University Medical Center, in Durham, N.C. about the novel interferon treatment.

“Improved tolerability, together with faster time to virologic response, supports the further assessment of lambda-based direct-acting antiviral combination regimens in patients chronically infected with HCV genotypes 1 or 4,” said Andrew J. Muir, MD, MHS, clinical director of hepatology at Duke Uni...

Interferon (IFN)-free therapies are on the horizon for patients with Hepatitis C (HCV) infection. In this article we sha...
03/01/2013
Potential IFN-Free Regimens For HCV

Interferon (IFN)-free therapies are on the horizon for patients with Hepatitis C (HCV) infection. In this article we share highlights from some of the trials of IFN-free therapies presented at the American Association for the Study of Liver Diseases (AASLD) meeting.

“We can see a light at the end of the tunnel,” said Guadalupe Garcia-Tsao, MD, professor of medicine at Yale University, New Haven, Conn., and chief of the section of digestive diseases at the Connecticut Veterans Affairs Healthcare System, West Haven, referring to a future that includes IFN-free re...

Infectious Disease Special Edition's cover photo
02/26/2013

Infectious Disease Special Edition's cover photo

Unsafe injections, that can lead to exposure of HIV, HCV and other IDs in patients, can happen anywhere. Read IDSE to he...
02/26/2013
Halting Unsafe Injection Practices Still a Challenge

Unsafe injections, that can lead to exposure of HIV, HCV and other IDs in patients, can happen anywhere. Read IDSE to hear more about a new CDC webinar drawing attention to this topic and to see the Safe Injection Practices Coalition's Injection Safety Checklist.

An infection spread by unsafe injection practices can happen anywhere. In 2008, it happened at an endoscopy clinic in Las Vegas. When a patient infected with hepatitis C was injected with propofol from a single-dose vial, backflow contaminated the syringe. Nurses reused the syringe to draw additiona...

Ezra Cohen, MD, a head and neck cancer specialist at the University of Chicago predicts HPV-positive oropharynx will be ...
02/25/2013
Key Findings: HPV Cancers, Epidemiologic Trends

Ezra Cohen, MD, a head and neck cancer specialist at the University of Chicago predicts HPV-positive oropharynx will be the most common virally associated cancer that physician's will see in the near future.

Chicago—A sharp rise in the incidence of human papillomavirus (HPV)–associated cancer of the oropharynx—in stark contrast to steady declines in HPV-unrelated oropharyngeal cancer due to decreases in smoking—virtually guarantees that clinicians will soon begin to see patients with this disease in the...

02/22/2013
CDC Issues Guidance on Prevention of Infectious Diseases in IV Drug Users

The CDC recently released summary guidance on the prevention of infectious disease for those who use illegal drugs. IDSE spoke with Diana Sylvestre, MD an assistant clinical professor of medicine at the University of California, San Francisco about the new guidelines.

The Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS) have issued a summary guidance on the prevention of infectious diseases in users of illicit drugs (MMWR Recomm Rep 2012;61[RR-5]:1-40). Focusing on integrated prevention services, the repo...

12/04/2012
Liver Meeting Roundup

Research highlights on viral hepatitis and HIV from the Liver Meeting 2012.

Boston—The Liver Meeting 2012 featured the latest in research, treatment guidelines and advances in the field of hepatology. Here, we highlight some the most compelling presentations related to treatment for patients infected with the hepatitis C virus (HCV) and HIV.

A specialized Walgreens pharmacy program for HIV improved treatment adherence and persistence compared with traditional ...
12/04/2012
HIV-Specialized Pharmacies May Improve Adherence

A specialized Walgreens pharmacy program for HIV improved treatment adherence and persistence compared with traditional programs.

Community pharmacies that offer specialized services for HIV/AIDS patients may be more effective than traditional community pharmacies in improving adherence and persistence with antiretroviral therapy, according to a study in AIDS Patient Care and STDs (2012;26:526-531).

11/26/2012
NABP Issues Plan to Boost Compounding Safety

In response to the ongoing NECC meningitis outbreak, the National Association of Boards of Pharmacy has created an action plan to identify and inspect sterile and nonsterile compounding pharmacies.

The release of the NABP action plan on Tuesday came a day after the U.S. Senate Committee on Health, Education, Labor and Pensions, or HELP, sent a letter to all 50 state boards of pharmacy seeking details of how they oversee the nation’s more than 3,000 compounding pharmacies. The letter was part o...

A new report from the AHRQ showed that hospitalizations from Clostridium difficile infections have more than doubled ove...
11/21/2012
Dramatic Rise in Hospital Visits for C. difficile

A new report from the AHRQ showed that hospitalizations from Clostridium difficile infections have more than doubled over the past 10 years despite increased awareness about this pathogen.

Despite efforts by the U.S. Department of Health and Human Services and antimicrobial stewardship programs to combat Clostridium difficile infections (CDIs), the national rate of hospitalizations related to these infections is projected to more than double from 2001 to 2012, according to a report fr...

A new report from the AHRQ showed that hospitalizations from Clostridium difficile infections have more than doubled ove...
11/21/2012
Dramatic Rise in Hospital Visits for C. difficile

A new report from the AHRQ showed that hospitalizations from Clostridium difficile infections have more than doubled over the past 10 years despite increased awareness about this pathogen.

Despite efforts by the U.S. Department of Health and Human Services and antimicrobial stewardship programs to combat Clostridium difficile infections (CDIs), the national rate of hospitalizations related to these infections is projected to more than double from 2001 to 2012, according to a report fr...

11/16/2012
Universal MRSA Decolonization Beats Screening

A mandatory decolonization strategy for MRSA in the ICU prevents more bloodstream infections than standard screen-and-react methods, according to data presented at IDWeek 2012.

Address

New York, NY

Telephone

212-957-5300

Website

Alerts

Be the first to know and let us send you an email when Infectious Disease Special Edition posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Infectious Disease Special Edition:

Category

Nearby media companies